The Korean Journal of Helicobacter and Upper Gastrointestinal Research

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment of Helicobacter pylori Infection: A Pilot Study

Tae Jun Kim, Jeung Hui Pyo, Hyuk Lee, Yang Won Min, Byung Hoon Min, Jun Haeng Lee, Jae J Kim

Korean J Helicobacter Up Gastrointest Res. 2017;17(3):132-137. Published online September 10, 2017
DOI: https://doi.org/10.7704/kjhugr.2017.17.3.132

Clinical Efficacy of Gemifloxacin-containing Triple Therapy for First-line Treatment ofHelicobacter pyloriInfection: A Pilot Study

Tae Jun Kim, Jeung Hui Pyo, Hyuk Lee, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Jae J. Kim

The Korean Journal of Helicobacter and Upper Gastrointestinal Research. 2017;17(3):132

Link1 Link2 Link3

A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment ofHelicobacter pyloriInfection: A Pilot Study

Antonio Francesco Ciccaglione, Luigina Cellini, Laurino Grossi, Lamberto Manzoli, Leonardo Marzio

Helicobacter. 2015;20(5):390-396

Link1 Link2

Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment ofHelicobacter pyloriInfection: Two Pilot Studies

Antonio Francesco Ciccaglione, Roberta Tavani, Laurino Grossi, Luigina Cellini, Lamberto Manzoli, Leonardo Marzio

Helicobacter. 2016;21(5):375-381

Link1 Link2

Moxifloxacin-Tetracycline-Lansoprazole Triple Therapy for First-Line Treatment of Helicobacter pylori Infection: A Prospective Study

Adnan Taş, Erdem Akbal, Erdem Koçak, Seyfettin Köklü

Helicobacter. 2011;16(1):52-54

Link1 Link2

Moxifloxacin-Containing Triple Therapy versus Bismuth-Containing Quadruple Therapy for Second-Line Treatment of Helicobacter pylori Infection: A Meta-Analysis

Cheng Wu, Xiao Chen, Jing Liu, Ming-Yang Li, Zi-Qi Zhang, Zhi-Qiang Wang

Helicobacter. 2011;16(2):131-138

Link1 Link2

Comparison of Lafutidine and Rabeprazole in 7-day Second-line Amoxicillin- and Metronidazole-Containing Triple Therapy for Helicobacter pylori: A Pilot Study

Takahiko Kudo, Haruka Fujinami, Takayuki Ando, Jun Nishikawa, Kohei Ogawa, Ayumu Hosokawa, Tadahiro Orihara, Jun Murakami, Terumi Takahara, Toshiro Sugiyama

Helicobacter. 2012;17(4):277-281

Link1 Link2

Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate

Hyuk Yoon, Nayoung Kim, Byoung Hwan Lee, Tae Jun Hwang, Dong Ho Lee, Young Soo Park, Ryoung Hee Nam, Hyun Chae Jung, In Sung Song

Helicobacter. 2009;14(5):429-437

Link1 Link2

Su1691 Moxifloxacin Containing Triple Therapy vs. Moxifloxacin and Bismuth-Containing Quadruple Therapy for First-Line Treatment of Helicobacter pylori (H. pylori) Infection

Antonio Francesco Ciccaglione, Luigina Cellini, Laurino Grossi, Ada Maria Di tullio, Mauro Pagliaro, Roberta Tavani, Sila Cocciolillo, Leonardo Marzio

Gastroenterology. 2012;142(5):S-482

Link1 Link2

P.19.2 MOXIFLOXACIN CONTAINING TRIPLE THERAPY VS. MOXIFLOXACIN AND BISMUTH-CONTAINING QUADRUPLE THERAPY FOR FIRST-LINE TREATMENT OF HELICOBACTER PYLORI (H. PYLORI) INFECTION

A.F. Ciccaglione, L. Cellini, L. Grossi, A.M. Di Tullio, M. Pagliaro, R. Tavani, S. Cocciolillo, L. Marzio

Digestive and Liver Disease. 2012;44:S208

Link1 Link2

Meta-Analysis: Lactobacillus Containing Quadruple Therapy Versus Standard Triple First-Line Therapy for Helicobacter pylori Eradication

Jian Zou, Jie Dong, Xiaofeng Yu

Helicobacter. 2009;14(5):449-459

Link1 Link2